Primary prevention of congenital abnormalities due to high fever related maternal diseases by antifever therapy and folic acid supplementation

Current Women's Health Reviews

Volumn 3, Issue 3, 2007, Pages 190-201

  Czeizel, Andrew E ^a,b,c   Ács, Nándor ^a,b,c   Bánhidy, Ferenc ^a,b,c   Puhó, Erzsébet H ^a,b,c   Vogt, Gábor ^a,b,c  

^a FOUNDATION FOR THE COMMUNITY CONTROL OF HEREDITARY DISEASES   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c Hospital of the National Railways   (Hungary)

Author keywords

Antifever drugs; Congenital abnormalities; Fever related maternal diseases; Folic acid and supplementation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIPYRETIC AGENT; DIPYRONE; FOLIC ACID; PARACETAMOL;

CARDIOVASCULAR DISEASE; CLEFT LIP FACE PALATE; CLINICAL EVALUATION; COMMON COLD; CONGENITAL CATARACT; CONGENITAL MALFORMATION; DRUG MEGADOSE; FEVER; HEAT STRESS; HERPES; HUMAN; HYPERTHERMIA; INFLUENZA; MATERNAL DISEASE; NEURAL TUBE DEFECT; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TERATOGENICITY;

EID: 34548311559     PISSN: 15734048     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340407781387708     Document Type: Review

References (79)

1. Czeizel AE, Intody Zs, Modell B. What proportion of congenital abnormalities can be prevented? Brit Med J 1993; 306: 499-503.
2. Czeizel AE. The first 25 years of the Hungarian Congenital Abnormality Registry. Teratology 1997; 55: 299-305.
3. Czeizel AE, Rockenbsuer M, Siffel Cs, Varga E. Description and mission evaluation of the Hungarian Case-Control Surveillance of Congenital Abnormalities, 1980-1996. Teratology 2001; 63: 176-85.
4. Rockenbauer M, Olsen J, Czeizel AE, Pedorsen L, Sovensen HT. Recall bias in a case-control study on the use of medicine during pregnancy. Epidemiology 2001; 12: 461-6.
5. Czeizel AE, Ács N, Bánhidy F, Vogt G. Possible association between maternal diseases and congenital abnormalities. In: Engels JV (ed): Birth Defects New Research. NOVA Scientific Publ New York. 2006; pp.55-70.
6. Ács N, Bánhidy F, Puhó E, Czeizel AE. Maternal influenza during pregnancy and risk of congenital abnormalities in the offspring. Birth Defects Res Part A 2005; 73: 989-90.
7. Ács N, Bánhidy F, Puhó E, Czeizel AF. Population-based case-control study of the common cold during pregnancy and congenital abnormalities. Eur J Epidemiol 2006; 21: 65-75.
8. Bánhidy F, Puhó E, Acs N, Czeizel AE. Possible indirect association between maternal recurrent orofacial herpes in pregnancy and a higher risk for congenital abnormalities, J Turk-German Gynec Ass 2007; 111: 1-11.
9. Czeizel AE, Medveczky E. Periconceptional multivitamin supplementation and multimalformed offspring. Obstet Gynecol 2004; 102: 1255-61
10. Czeizel AE, Puhó HE, Bánhidy F. No association between periconceptional multivitamin supplementation and risk of multiple congenital abnormalities. A population-based case-control study. Am J Med Genet Part A 2006; 140A: 2469-77.
11. Ács N, Bánhidy F, Puhó E, Czeizel AE. Acute respiratory infections during pregnancy and congenital abnormalities: A case-control study. Cong Anom (Kyoto) 2006; 40: 86-96.
12. Bánhidy F, Ács N, Puhó HE, Czeizel AE. Maternal urinary tract infection and related drug treatments and risk of congenital abnormalities in the offspring. Brit J Obstet Gynecol 2006; 113: 1465-71.
13. Bánhidy F, Ács N, Puhó HE, Czeizel AE. Associations between inflammatory diseases of the female genital tract in pregnant women and congenital abnormalities. Eur J Obstet Gynecol Reprod Biol 2007. (submitted)
14. Medveczky E, Puhó E, Czeizel AE. The evaluation of maternal illnesses in the origin of neural-tube defects. Arch Gynecol Obstet 2004; 270: 244-51.
15. Métneki J, Puhó E, Czeizel AE. Maternal diseases and isolated orofacial clefts in Hungary. Birth Defects Res Part A 2005; 73: 617-23.
16. Vogt G, Szunyogh M, Czeizel AE. Birth characteristics of different ocular congenital abnormalities in Hungary. Ophthalmic Epidemiol 2006; 13: 159-66.
17. Vogt G, Puhó E, Czeizel AE. A population-based case-control study of isolated congenital cataract. Birth Defects Res Part A 2005; 73: 997-1005.
18. Czeizel AE, Puhó HE, Ács N, Bánhidy F. High fever related maternal disease as a possible cause of multiple congenital abnormalities: a population-based case-control study. Birth Defects Res Part A 2007 [Epub ahead of print].
19. Czeizel AE, Puho HE, Ács N, Bánhidy F. The delineation of a multiple congenital abnormality syndrome in the offspring of pregnant women affected wit high fever related maternal disorders - a population-based study. Birth Defect Res Part A (submitted)
20. Edwards MJ. Hyperthemia as a teratogen: A review of experimental studies and their clinical significance. Teratogen Carcinogen Mutagen 1986; 6: 563-82.
21. Brinsmade AB, Rubsaamen H. Zur Teratogenetischen Wirkung von. Unspezifischem Fieber auf den sich Entwickelnden Kaninchenembryo. Beitr Pathol Anat 1957; 117: 154-64.
22. Skreb N, Frank Z. Developmental abnormalities in the rat induced by heat shock. J Embryol Exp Morphol 1963; 11: 445-57.
23. Edwards MJ. Congenital defects in guinea pigs following induced hyperthermia during gestation. Arch Pathol 1967; 84:42-7.
24. Edwards MJ. Congenital defects in guinea pigs: Prenatal retardation of brain growth of guinea pigs following hyperthermia during gestation. Teratology 1969; 2: 239-45.
25. Edwards MJ. Congenital defects in guinea pigs: Fetal resorptions, abortions and malformations following induced hyperthermia during early gestation. Teratology 1969; 2: 313-28.
26. Edwards MJ. The experimental production of arthrogryposis multiplex congenita in guinea pigs by maternal hyperthermia during gestation. J Pathol 1971; 104: 221-6.
27. Edwards MJ. Apoptosis, the heat shock response, hyperthermia, birth defects, diseases and cancer: where are the common links? Cell Stress Charperones 1998; 3: 213-20.
28. Hartley WJ, Alexander G, Edwards MJ. Brain cavitation and microcephaly in lambs exposed to prenatal hyperthermia. Teratology 1974; 9: 299-304.
29. Kilham L, Ferm VH. Exencephaly in fetal hamsters exposed to hyperthermia. Teratology 1976; 14: 323-6.
30. Webster WS, Edwards MJ. Hyperthermia and the induction of neural tube defects in mice. Teratology 1984; 29: 417-25.
31. Harding AJ, Edwards MJ. Micrencephaly in rats caused by maternal hyperthermia on days 13 and 14 of pregnancy. Cong Anom (Kyoto) 1993; 33: 203-9.
32. Sasaki J, Yamaguchi A, Nabeshima Y, Shigemitsu S, Mesaki H, Kubo T. Exercise at high temperature causes maternal hyperthermia and fetal anomalies in rats. Teratology 1995; 51: 233-6.
33. Smith M, Edwards MJ, Waugh P. Maternal hyperthermia and the formation of cataracts in the lens of the embryonic and fetal guinea pig. Cong Anom (Kyoto) 1996; 36: 7-19.
34. Cokroft DL, New DAT. Abnormalities induced in rat embryos by hyperthermia. Teratology 1978; 17: 277-84.
35. Mirkes, PE. Effects of acute exposures to elevated temperatures on rat embryo growth and development in vitro. Teratology 1985; 32: 259-66.
36. German MA, Webster WS, Edwards MJ. Hyperthermia as a teratogen: Parameters determining hyperthermia-induced head defects in the rat. Teratology 1985; 31: 265-72.
37. Shiota K. Induction of neural tube defects and skeletal malformations in mice following brief hyperthermia in utero. Biol Neonat 1988; 53: 86-97.
38. Rao GS, Abraham V, Fink BA, Margulies N, Ziskin MC. Biochemical changes in the developing rat central nervous system due to hyperthermia. Teratology 1990; 41: 327-32.
39. Mirkes PE. Molecular/cellular biology of the heat stress response and its role in agent-induced teratogenesis. Mutat Res 1997; 396: 163-73.
40. Mirkes PE, Cornel LM, Park HW, Cunningham ML. Induction of thermotolerance in early postimplantation rat embryos is associated with increased resistance to hyperthermia induced apoptosis. Teratology 1997; 56:210-9.
41. Umpierre CC, Little SA, Mirkes PE. Co-localization of active caspase-3 and DNA fragmentation (TUNEL) in normal and hyperthermia-induced abnormal mouse development. Teratology 2001; 63: 134-43.
42. Little SA, Mirkes PE. Increased levels of 3 pro-apoptotic Bcl-2 genes, NOXA, PUMA and DP5, in day 9 mouse embryos exposed to hyperthermia (HS) or 4-hydroperoxycyclophosphamide (4-CP). (Abst) Birth Defects 2003; 67: 323.
43. Finnel RH, Moon SP, Abbott LC, et al. Strain differences in heat-induced neural-tube defects in mice. Teratology 1986; 33: 247-52.
44. Lundberg YW, Wing MJ, Xiong W, Zhao J, Finnell RH. Generic dissection of hyperthermia-induced neural tube defects in mice. Birth Defects Res Part A 2003; 67: 409-13.
45. Harding AJ, Edwards MJ. As a result of prenatal hyperthermia three week old rats display microcephaly absent in the newborn. Teratology 1992; 44: 477-8.
46. Edwards MJ, Shiota K, Walsh DA, Smith MS. Hyperthermia and birth defects. Reprod Toxicol 1995; 9: 411-25.
47. Chambers CD. Risks of hyperthermia associated with hot tub or spa use by pregnant women. Birth Defects Res Part A 2006; 76: 569-73.
48. Chance PF, Smith DW. Hyperthermia and meningomyelocele and anencephaly. Lancet 1978; 1: 769-70.
49. Halperin LR, Wilroy RS. Maternal hyperthermia and neural-tube defects. Lancet 1978; 2: 212-213.
50. Miller P, Smith DW, Shepard TH. Hyperthermia as a possible cause of anencephaly. Lancet 1978; 1 (8063): 519-21.
51. Clarren SK, Smith DW, Harvey MAS, Ward RH, Myrianthopoulos NC. Hyperthermia: A prospective evaluation of a possible teratogenic agent in man. J Pediatr 1979; 95: 81-3.
52. Layde PM, Edmonds LD, Erickson JD. Maternal fever and neural tube defects. Teratology 1980; 21: 105-8.
53. Fisher NL, Smith DW. Occipital encephalocele and early gestational hyperthermia. Pediatrics 1981; 68: 480-3.
54. Shiota K. Neural-tube defects and maternal hyperthermia in early pregnancy. Epidemiology in a human embryo population. Am J Med Genet 1982; 12:281-8.
55. Hunter AGW. Neural tube defects in eastern Ontario and western Qebec: Demography and family data. Am J Med Genet 1984; 19: 45-63.
56. Lynberg MC, Khoury MJ, Lu X, Cocian T. Maternal flu, fever, and the risk of neural-tube defects: a population-based case-control study. Am J Epidemiol 1994; 140: 244-55.
57. Suarez L, Felkner M, Hendricks K. The effect of fever, febrile illnesses, and heat exposure on the risk of neural-tube defects in a Texas-Mexico border population. Birth Defects Res Part A 2004; 70: 815-9.
58. Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever, and medication use as risk factors of neural-tube defects. Teratology 1998; 57: 1-7.
59. Shaw GM, Lammer EJ, Carmichael SL, Finnell RH. Interaction between host susceptibilities and exogenous exposures in birth defects research: An epidemiologic perspective. (Abst) Birth Defects 2003; 67: 334.
60. Smith DW, Clarren SK, Harvey MA. Hyperthermia as a possible teratogenic agent. J Pediatr 1978; 92: 878-83.
61. Fraser FC, Skelton J. Possible teratogenicity of maternal fever. Lancet 1978; 2: 634.
62. Tikkanen J, Heinonen OP. Maternal hyperthermia during pregnancy and cardiovascular malformations in the offspring, Eur J Epidemiol 1991; 7: 628-35.
63. Botto LD, Lynberg MC, Erickson JD. Congenital heart defects, maternal febrile illness, and multivitamin use: a population-based study. Epidemiology 2001; 12: 485-90.
64. Botto LD, Erickson JD, Mulinare J. Maternal fever, multivitamin use, and selected birth defects: evidence of interaction? Epidemiology 2002; 13:485-8.
65. Little BB, Ghali FE, Snell LM, Knoll KA, Johnston W, Gilstrap III LC. Is hyperthermia terstogenic in the human. Am J Perinat 1991; 8: 185-9.
66. Graham JM, Edwards MJ, Lipson AH, Webster WS. Gestational hyperthermia as a cause for Moebius syndrome. Teratology 1988; 37(5):461-2.
67. Lipson AH, Webster WS, Brown-Woodman PDC, Osborn RA. Moebius syndrome: annual model - human correlations and evidence for a brainstem vascular etiology. Teratology 1989; 40: 339-50.
68. Lipson AH. Hirschsprung diseases in the offspring of mothers exposed to hyperthermia during pregnancy. Am J Med Genet 1988; 29:117-24.
69. Abe K, Honein MA, Morre CA. Maternal febrile illnesses, medication use, and the risk on congenital renal anomalies. Birth Defects Res Part A 2003; 67: 911-8.
70. Kleinbrecht J, Michaelis H, Michaelis J, Koller S. Fever in pregnancy and congenital defects. Lancet 1979; 1: 1403.
71. Chambers CD, Johnson KA, Di LM, Felix RJ, Jones KL. Maternal fever and birth outcome: A prospective study. Teratology 1998; 58: 251-7.
72. Germain M-A, Webster W, Edwards JM. Hyperthermia as a teratogen: parameters determining hyperthermia-induced head defects in the rat Teratology 1985; 31: 265-72.
73. Jones KL. Hyperthermia-induced spectrum of defects. In: Jones KL. Smiths Recognizable Patterns of Human Malformation. 6th ed. WB Saunders Co. Philadelphia. 2004, pp. 516-9.
74. Czeizel AE, Dudás I. Prevention of first occurrence of neural-tube defects by periconceptional vimmin supplementation. N Engl J Med 1992; 327:1832-5.
75. Bánhidy F, Lowry BR, Czeizel AE. Risk and benefit of drug use during pregnancy. Int J Med Sci 2005; 2: 100-6.
76. Czeizel AE. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Brit Med J 1993; 306: 1645-8.
77. Czeizel AE. Reduction of urinary tract and cardiovascular defects by periconceptional multivitamin supplementation. Am J Med Genet 1996; 62: 179-83.
78. Czeizel AE, Dobó M, Vargha P. Hungarian cohort-controlled trial of periconceptional multivitamin supplementation shows a reduction of certain congenital abnormalities. Birth Defects Res Part A 2004; 70: 853-61.
79. Shin JH, Shiota K. Folic acid supplementation of pregnant mice suppresses heat-induced neural-tube defects in the offspring. J Nutr 1999; 129: 2070-3.